Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite potential risks. Read more on BMY here.
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the debilitating mental disorder in over seven decades.
2d
on MSN
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia ...
Business Wire
2d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
WFAE
2d
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Grammy-winning singer dies
Helene death toll rises
Actor John Ashton dies
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Rescue mission launched
Hospitalized for burns
'SNL' launches 50th season
Congestion fee bid denied
Steward CEO to step down
Faces fine to end Brazil ban
Congressional Gold Medal
Ga. chemical plant fire
ISR airstrike kills Qaouk
Dow closes at record high
‘Wild Robot' tops box office
Malibu coast earthquake
Earth's orbit new asteroid
NC small plane crash
Houthis attack US warships
Chief adviser subpoenaed
Temporary outage fixed
Ukrainian drones shot down
Haney sues Garcia
121st loss of the season
Condemns Israeli strikes
Newsom vetoes AI safety bill
37 militants killed in Syria
Trump's Erie rally
UNC digital IDs blocked
Human rabies death in MN
Feedback